Urology · Ada, OK
NPI
1588659957
Since 2005
Specialty
Urology
Code 174400000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1414 Arlington St, Suite 2300
Ada, OK, 74820
Phone (580) 332-0112
Groups this clinician bills Medicare through
Medicare paid, 2024
$431K
5,585 services
Medicare patients, 2024
1,152
Average age 75
Drug cost, 2024
$558K
5,574 prescriptions
Company payments, 2025
$189
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Glen E Diacon Jr. was code 99214 (office e&m - established), 1,674 times for 846 patients. In total Glen E Diacon Jr. billed 5,585 services in 72 codes, and Medicare paid $431K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,674 | 846 | $78.78 | $132K |
| 81003 Clinical Chemistry | Office | 1,154 | 644 | $2.18 | $2,512 |
| 74420 Standard X-ray | Facility | 419 | 312 | $17.88 | $7,494 |
| 99232 Hospital E&M - Subsequent | Facility | 311 | 93 | $58.09 | $18K |
| 52000 Cystourethroscopy | Office | 269 | 245 | $154.69 | $42K |
| 51798 Ultrasound - Nonspecific | Office | 257 | 222 | $6.31 | $1,621 |
| 50590 Calculus Removal - Urinary | Facility | 251 | 183 | $410.20 | $103K |
| 51741 Test - Miscellaneous | Office | 225 | 199 | $8.37 | $1,884 |
| 52442 Cystourethroscopy | Facility | 108 | 36 | $37.13 | $4,010 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 106 | 17 | $138.19 | $15K |
| 52281 Calculus Removal - Urinary | Office | 83 | 24 | $212.59 | $18K |
| 52332 Cystourethroscopy | Facility | 60 | 42 | $75.19 | $4,511 |
| 51702 Other Organ Systems | Office | 45 | 22 | $42.68 | $1,921 |
| 76872 Ultrasound - Nonspecific | Office | 43 | 43 | $95.46 | $4,105 |
| 99233 Hospital E&M - Subsequent | Facility | 41 | 41 | $88.31 | $3,621 |
By year: 2022 $418K for 5,540 services; 2023 $447K for 5,563 services; 2024 $431K for 5,585 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,154 | 644 | $2.18 | $2,512 |
Medicare prescription drug claims, 2024
In 2024, the drug Glen E Diacon Jr. prescribed most often to Medicare patients was Tamsulosin Hcl, with 759 prescriptions and refills. In total Glen E Diacon Jr. wrote 5,574 Medicare prescriptions that cost $558K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 759 | 1,457 | 199 | $11K |
| Ciprofloxacin Hcl Generic | 546 | 546 | 399 | $4,096 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 482 | 482 | 327 | $1,673 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 471 | 575 | 105 | $14K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 232 | 249 | 144 | $1,189 |
| Oxybutynin Chloride Generic | 209 | 268 | 80 | $4,121 |
| Methenamine Hippurate Generic | 203 | 273 | 53 | $5,532 |
| Escitalopram Oxalate Generic | 196 | 196 | 19 | $3,095 |
| Levofloxacin Generic | 193 | 195 | 140 | $1,075 |
| Cephalexin Generic | 176 | 238 | 97 | $1,768 |
| Testosterone Cypionate Generic | 107 | 283 | 44 | $5,481 |
| Omeprazole Generic | 94 | 102 | Under 11 | $882 |
| Myrbetriq Mirabegron | 89 | 141 | 21 | $62K |
| Cefdinir Generic | 70 | 70 | 55 | $1,166 |
| Doxycycline Hyclate Generic | 68 | 72 | 42 | $1,450 |
Brand drugs: - claims; generic drugs: 5,243 claims; opioid claims: 532.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Glen E Diacon Jr. $189 ($189 in general payments such as food, travel and fees) from 7 companies. The largest payer was DePuy Synthes Sales Inc. with $67.24.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.